Cardiac (123)I-meta-iodobenzylguanidine (MIBG) uptake in dementia with Lewy bodies: comparison with Alzheimer's disease

Benzer Materyaller

• A clinical role for [(123)I]MIBG myocardial scintigraphy in the distinction between dementia of the Alzheimer's-type and dementia with Lewy bodies
  Yazar:: Yoshita, M, ve diğerleri
  Baskı/Yayın Bilgisi: (2001)
• Onset age and severity of motor impairment are associated with reduction of myocardial (123)I-MIBG uptake in Parkinson's disease
  Yazar:: Hamada, K, ve diğerleri
  Baskı/Yayın Bilgisi: (2003)
• Diagnostic Accuracy of (123)I-Meta-Iodobenzylguanidine Myocardial Scintigraphy in Dementia with Lewy Bodies: A Multicenter Study
  Yazar:: Yoshita, Mitsuhiro, ve diğerleri
  Baskı/Yayın Bilgisi: (2015)
• Diagnosis of dementia with Lewy bodies: can (123)I-IMP and (123)I-MIBG scintigraphy yield new core features?
  Yazar:: Sakamoto, Fumi, ve diğerleri
  Baskı/Yayın Bilgisi: (2017)
• HIV Dementia with a Decreased Cardiac (123)I-metaiodobenzylguanidine Uptake Masquerading as Dementia with Lewy Bodies
  Yazar:: Kurihara, Masanori, ve diğerleri
  Baskı/Yayın Bilgisi: (2018)